Eclipse Home Medical | |
570 E 1700 S, Ste 204, Clearfield, Utah 84015 | |
(801) 217-3551 |
Name | Eclipse Home Medical |
---|---|
Organization Name | Eclipse Mobility Llc |
Location | 570 E 1700 S, Ste 204, Clearfield, Utah 84015 |
Type | DME Supplier - Customized Equipment |
Phone | (801) 217-3551 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New evidence unearthed by archaeologists from The Australian National University (ANU) shows that modern humans colonised the island of Madagascar thousands of years later than previously thought.
ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.
Millions of Americans suffer from neurodegenerative diseases such as Alzheimer's and Parkinson's. Researchers have identified promising new treatments, such as cerebrolysin, but current clinical approaches are ineffective because critical concentrations of the drug dissipate within the body before reaching the blood-brain barrier and central nervous system.
With implementation of conservative treatment methods like physiotherapy and individually tailored, adjusted exercises, quality of osteoarthritis care can improve and patients can delay the need for an artificial hip or knee joint.
› Verified 5 days ago
NPI Number | 1588011688 |
Organization Name | ECLIPSE MOBILITY, LLC |
Type | DME Supplier - Customized Equipment |
Address | 1051 S 500 W Ste D, Woods Cross, UT 84010 |
Phone Number | 801-217-3551 |
News Archive
New evidence unearthed by archaeologists from The Australian National University (ANU) shows that modern humans colonised the island of Madagascar thousands of years later than previously thought.
ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.
Millions of Americans suffer from neurodegenerative diseases such as Alzheimer's and Parkinson's. Researchers have identified promising new treatments, such as cerebrolysin, but current clinical approaches are ineffective because critical concentrations of the drug dissipate within the body before reaching the blood-brain barrier and central nervous system.
With implementation of conservative treatment methods like physiotherapy and individually tailored, adjusted exercises, quality of osteoarthritis care can improve and patients can delay the need for an artificial hip or knee joint.
› Verified 5 days ago
News Archive
New evidence unearthed by archaeologists from The Australian National University (ANU) shows that modern humans colonised the island of Madagascar thousands of years later than previously thought.
ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.
Millions of Americans suffer from neurodegenerative diseases such as Alzheimer's and Parkinson's. Researchers have identified promising new treatments, such as cerebrolysin, but current clinical approaches are ineffective because critical concentrations of the drug dissipate within the body before reaching the blood-brain barrier and central nervous system.
With implementation of conservative treatment methods like physiotherapy and individually tailored, adjusted exercises, quality of osteoarthritis care can improve and patients can delay the need for an artificial hip or knee joint.
› Verified 5 days ago
Eclipse Home Medical Type: DME Supplier - Customized Equipment Location: 570 E 1700 S, Clearfield, Utah 84015 Phone: (801) 217-3551 |